Regulation of orthopaedic devices: Future implications for research and innovation.
PMID : 37608857 ·
C, l, a, i, r, e, , A, , D, o, n, n, e, l, l, e, y, ;, , V, i, n, c, e, n, t, , J, , D, e, v, l, i, n, ;, , M, i, t, c, h, e, l, , B, , H, a, r, r, i, s, ;, , R, o, b, e, r, t, , A, , P, o, g, g, i, e, ;, , R, o, y, , W, , S, a, n, d, e, r, s, ;, , S, a, a, m, , M, o, r, s, h, e, d
Publicité
Résumé
The conception-to-market development of orthopaedic devices occurs across the total product life cycle including device design and preclinical testing, clinical investigations to support marketing applications, and monitoring of device performance after market introduction. This process involves industry, regulatory agencies, health care providers, engineers, scientists, and patients. The Food and Drug Administration (FDA) is responsible for regulating medical devices in the United States, and u
Publicité
Source officielle
Voir sur PubMed →Données issues de PubMed / NCBI. Pour le texte intégral et les informations les plus récentes, consultez toujours la notice officielle.